Browse studies

Find your next paid study

27,333 recruiting studies available now

Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum

This is a study to find out if a device that temporarily alters brain activity (repetitive transcranial magnetic stimulation, rTMS) might be used to change how…

Anxiety Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical University of South CarolinaNCT04824105

A Long-Term Follow-up Study for Subjects With Chronic Hepatitis B Previously Treated With Imdusiran (AB-729)

This is a long term follow-up study for chronic hepatitis B (CHB) subjects who have received imdusiran treatment in a prior clinical trial, stopped NA therapy …

Long Term Follow-up

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Arbutus Biopharma CorporationNCT06277037

Phase 2

OVAFIT-TIL: A Phase Ib Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab in Recurrent Ovarian Cancer

Patients with recurrent ovarian cancer will undergo resection of a safely accessible metastatic lesion, from which tumor-infiltrating lymphocytes (TIL) will be…

Ovarian Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Medical University of South CarolinaNCT07720180

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

This is a 24-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible pa…

Psoriasis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

CorEvitasNCT07648602

Phase 1

A Pilot Study Evaluating the Toxicity and Clinical Benefit of Mitogen-activated Protein Kinase (MAPK) Pathway Inhibition Combined With Programmed Cell Death-1 Checkpoint Blockade (Anti-PD1) for the Treatment of BRAF-altered Pediatric Gliomas

Pediatric gliomas harboring BRAF-alterations, commonly BRAFV600 mutation or KIAA1549-BRAF fusion, are currently treated with either chemotherapy or mitogen act…

Low Grade GliomaHigh Grade Glioma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Ann & Robert H Lurie Children's Hospital of ChicagoNCT06712875

Phase 1

BrainMet ADePPT (Anticancer Drug Penetration Platform Trial)

The researchers are doing this study to find out how effective sotorasib is at getting into KRAS G12C+ brain tumors. The researchers will also find out whether…

Brain Tumor

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT06807619

Phase 1

A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-002 in Participants With Von Willebrand Disease (Velora Pioneer)

This is a first-in-human (FIH), Phase 1/2, 3-part open-label, dose escalation, safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and efficacy s…

Von Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1Von Willebrand Disease (VWD), Type 2+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Hemab ApSNCT06754852

The BHFS Study (Better, Harder, Faster, Stronger): Does Neoadjuvant Chemotherapy Improve Fitness for Surgery?

The purpose of this study is to evaluate changes in the electronic Frailty Index (eFI) score following 3-4 cycles of neoadjuvant chemotherapy (NACT) in partici…

Frailty at Older AdultsOvarian CancerEndometrial Cancer+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT07220512

Observational

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

This trial studies how well nutrition and exercise interventions work in reducing androgen deprivation therapy-induced obese frailty in prostate cancer survivo…

Cancer SurvivorObesityOverweight+17 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)

The objective of this study is to demonstrate that cytokine-induced memory-like natural killer cells can be generated from donor cells and infused safely into …

Acute Myeloid Leukemia

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT05580601

Phase 1

An Open-Label, Multicenter, Phase 1 Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of TLN-121 as a Single Agent and in Combination With Other Anti-Lymphoma Agents, in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

The primary purpose of this study is to evaluate the safety, pharmacokinetics,, and preliminary anti-tumor activity of TLN-121 as a single agent and in combina…

LymphomaLymphoma, Non Hodgkin

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Treeline Biosciences, Inc.NCT07082803

Phase 4

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in dietary sodium intake on skin sodium levels…

Atopic Dermatitis (Eczema)Psoriasis

Estimated

~$25 – $900

Actual pay is set by the research site.

University of California, San FranciscoNCT07487831